Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saline placebo is a pharmacologically inactive solution of sodium chloride in water, utilized as a control arm in clinical research. In the specific trial conducted by the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, this saline solution was administered as an oral rinse to evaluate the efficacy of 0.12% chlorhexidine gluconate for the decolonization of *Staphylococcus aureus* in the oropharynx of children aged 5-17 years. The placebo serves to account for the physical action of gargling and the psychological placebo effect, allowing for a controlled comparison against the active antimicrobial treatment. The study targeted pediatric patients with a history of skin and soft tissue infections (SSTIs) to determine if reducing oropharyngeal colonization could mitigate recurrent infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saline placebo-Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center-Staphylococcus aureus colonization.